4//SEC Filing
SCHEDER-BIESCHIN MAX 4
Accession 0001209191-18-036693
CIK 0001549084other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:29 PM ET
Size
8.9 KB
Accession
0001209191-18-036693
Insider Transaction Report
Form 4
SCHEDER-BIESCHIN MAX
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-05-10+9,250→ 81,110 total - Tax Payment
Common Stock
2018-05-10$1.51/sh−4,151$6,248→ 76,959 total - Exercise/Conversion
Restricted Stock Units
2018-05-10−9,250→ 27,750 total→ Common Stock (9,250 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Documents
Issuer
EKSO BIONICS HOLDINGS, INC.
CIK 0001549084
Entity typeother
Related Parties
1- filerCIK 0001342549
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 4:29 PM ET
- Size
- 8.9 KB